Your browser doesn't support javascript.
loading
Integrative spatial analysis reveals a multi-layered organization of glioblastoma.
Greenwald, Alissa C; Darnell, Noam Galili; Hoefflin, Rouven; Simkin, Dor; Mount, Christopher W; Gonzalez Castro, L Nicolas; Harnik, Yotam; Dumont, Sydney; Hirsch, Dana; Nomura, Masashi; Talpir, Tom; Kedmi, Merav; Goliand, Inna; Medici, Gioele; Laffy, Julie; Li, Baoguo; Mangena, Vamsi; Keren-Shaul, Hadas; Weller, Michael; Addadi, Yoseph; Neidert, Marian C; Suvà, Mario L; Tirosh, Itay.
Affiliation
  • Greenwald AC; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Darnell NG; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Hoefflin R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Simkin D; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Mount CW; Department of Pathology, Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gonzalez Castro LN; Department of Pathology, Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Neurology, Brigham and Women's
  • Harnik Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Dumont S; Department of Pathology, Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Hirsch D; Immunohistochemistry Unit, Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
  • Nomura M; Department of Pathology, Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Talpir T; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
  • Kedmi M; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Goliand I; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Medici G; Clinical Neuroscience Center, Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Laffy J; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Li B; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
  • Mangena V; Department of Pathology, Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Keren-Shaul H; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Weller M; Clinical Neuroscience Center, Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Addadi Y; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Neidert MC; Clinical Neuroscience Center, Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Neurosurgery, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Suvà ML; Department of Pathology, Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: suva.mario@mgh.harvard.edu.
  • Tirosh I; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. Electronic address: itay.tirosh@weizmann.ac.il.
Cell ; 187(10): 2485-2501.e26, 2024 May 09.
Article in En | MEDLINE | ID: mdl-38653236
ABSTRACT
Glioma contains malignant cells in diverse states. Here, we combine spatial transcriptomics, spatial proteomics, and computational approaches to define glioma cellular states and uncover their organization. We find three prominent modes of organization. First, gliomas are composed of small local environments, each typically enriched with one major cellular state. Second, specific pairs of states preferentially reside in proximity across multiple scales. This pairing of states is consistent across tumors. Third, these pairwise interactions collectively define a global architecture composed of five layers. Hypoxia appears to drive the layers, as it is associated with a long-range organization that includes all cancer cell states. Accordingly, tumor regions distant from any hypoxic/necrotic foci and tumors that lack hypoxia such as low-grade IDH-mutant glioma are less organized. In summary, we provide a conceptual framework for the organization of cellular states in glioma, highlighting hypoxia as a long-range tissue organizer.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma Limits: Humans Language: En Journal: Cell Year: 2024 Type: Article Affiliation country: Israel

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma Limits: Humans Language: En Journal: Cell Year: 2024 Type: Article Affiliation country: Israel